That was the headline on a piece on Biopolitical Times concerning the $2.6 million grant from the California stem cell agency to a Los Angeles subsidiary of a Korean business, headed by a controversial scientist.
Jesse Reynolds of the Center for Genetics and Society wrote skeptically about the explanations involved in the withdrawal, declaring that they "seemed a bit disingenuous."
"Regardless," he said, "the outcome is the right one."
A decision in the Korean copyright infringement case may have had some role in the pushed/jumped matter.
ReplyDeleteThat said, the decision on the grant should have been on the merits of the proposal, rather than on what Cha may or may not have done in papers at FS and JRM. Of the proposal, there was a lot that might have been questioned as to the timescale of human SCNT. The outcome may have been the right one, but maybe not for the reasons indicated by Reynolds.